De Novo DEN200026

Device
EndeavorRx
Contact
scott kellogg
De Novo number
DEN200026
Product code
QFT
Regulation
882.5803
Classification name
digital therapeutic software for attention deficit hyperactivity disorder
Decision
granted (DENG)
Decision date
2020-06-15
Date received
2020-04-16
Classification advisory
Obstetrics/Gynecology
Review advisory
Neurology
Type
Direct

Current FDA Classification#

Product code
QFT
Device name
Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder
Medical specialty
Obstetrics/Gynecology
Device class
2
Regulation
882.5803
Implant
N
Life sustain/support
N